(3) DC-mediated presentation of antigens and T cell-modulated immune responses: CD47 mAbs promote tumor cell phagocytic ingestion by DCs coupled with subsequent presentation of antigens to CD8+ T cells, eliciting an anticancer adaptive immune response [90]. The gene discussed is CD47; the disease is neoplasm.